Reducing pill burden and helping with medication awareness to improve adherence

Canadian Pharmacists Journal

Volumn 146, Issue 5, 2013, Pages 262-269

  Farrell, Barbara ^a,b   French Merkley, Véronique ^a   Ingar, Nafisa ^a,b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMLODIPINE PLUS ATORVASTATIN; BISOPROLOL; CALCIUM; FUROSEMIDE; GLICLAZIDE; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; ISPAGULA; LEVOTHYROXINE; METFORMIN PLUS SITAGLIPTIN; METHOCARBAMOL; PARACETAMOL; PRAMIPEXOLE; RANITIDINE; RISEDRONIC ACID; SALBUTAMOL; VITAMIN D;

AGED; AMNESIA; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CLINICAL ASSESSMENT; CONSTIPATION; DAILY LIFE ACTIVITY; DYSPNEA; FEMALE; HUMAN; MEDICATION COMPLIANCE; MINI MENTAL STATE EXAMINATION; PHARMACIST; PHYSIOTHERAPY; PROTOCOL COMPLIANCE; SCORING SYSTEM; WHEEZING;

EID: 84890181199     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.1177/1715163513500208     Document Type: Article

References (16)

1. Farrell B, Szeto W, Shamji S. Drug-related problems in the frail elderly (letter). Can Fam Physician 2011; 57:168.
2. Cipolle RD, Strand LM, Morley PC. Pharmaceutical care practice: the clinician's guide. New York: McGraw-Hill; 2004.
3. Winslade N, Bajcar J. Therapeutic thought process algorithm. Ottawa (ON): National Association of Pharmacy Regulatory Authorities; 2009. Available: www.napra.org/Content_Files/Files/algorithm.pdf (accessed Oct. 10, 2012).
4. Feldman HH, Jacova C, Robillard A, Garcia A, Chow T, Borri M. Diagnosis and treatment of dementia. CMAJ 2008;178(7):825-36.
5. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007;5(4): 345-51.
6. Alexander GC, Sayla MA, Holmes HM, Sachs GA. Prioritizing and stopping prescription medications. CMAJ 2006;174(8):1083-84.
7. Lerotić I, Baršić N, Stojsavljević S, Duvnjak M. Acid inhibition and the acid rebound effect. Dig Dis 2011;29(5):482-6.
8. Aronow WS. Treating hypertension in older adults. Drug Saf 2009;32:111-8.
9. Hajjar ER, Gray SL, Guay DR, et al. Geriatrics. In: Talbert RL, DiPiro JT, Matzke GR, Posey LM, Wells BG, Yee GC, eds. Pharmacotherapy: a pathophysiologic approach. 8th ed. New York: McGraw-Hill; 2011. Available: www.accesspharmacy.com.proxy.lib.uwaterloo.ca/content.aspx?aID=7967419 (accessed Oct. 22, 2012).
10. Parving HH, Brenner BM, McMurray JJ, et al. Aliskiren trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant 2009;24:1663-71.
11. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.
12. Gurwitz JH, Kalish SC, Bohn RL, et al. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol 1997;50:953-59.
13. Silverberg DS, Iaina A, Oksenberg A. Treating obstructive sleep apnea improves essential hypertension and quality of life. Am Fam Physician 2002;65:229-37.
14. Bangalore S, Kamalakkannan G, Parkar S, et al. Fixeddose combinations improve medication compliance: a metaanalysis. Am J Med 2007;120:713-9.
15. Leichter SB, Thomas S. Combination medications in diabetes care: an opportunity that merits more attention. Clin Diabetes 2003;21:175-8.
16. Dore N, French Merkley V, Monahan A. Intentional medication nonadherence in a geriatric day hospital. Can Pharm J (Ott) 2011;144:260-5.